Designer drug use is increasing at an alarming rate. New compounds are being identified on a weekly basis. Also referred to as “novel or new psychoactive substances”, they pose many analytical, interpretative and legal challenges.
Many compounds require targeted toxicological and drug chemistry analysis, i.e. they may not be detected in routine laboratory screening procedures. Understanding the scope of testing is one of many critical factors in the interpretation of laboratory test results.